The London Biotechnology Show 2026 (LBS26) is Europe’s flagship red biotechnology exhibition and conference, taking place on 18–19 November 2026 at ExCeL London.
The event brings together biotechnology and pharmaceutical companies, healthcare providers, researchers, investors, policymakers, startups, technology providers and other life sciences professionals to explore the latest innovations, exchange knowledge, build partnerships and accelerate opportunities across the biotechnology ecosystem.
LBS26 covers key areas including biopharmaceuticals and vaccines, gene and cell therapy, diagnostics and precision medicine, regenerative medicine and stem cells, bioinformatics and AI, biomanufacturing, digital health, clinical trials, CROs, and laboratory technologies.
Featuring an exhibition, conference, networking opportunities, Buyer Programme and Startup Showcase, the event provides a platform for the global biotech community to discover emerging technologies, connect with industry leaders and explore new opportunities across healthcare and life sciences.
18–19 November 2026 | ExCeL London